Oxford Nanopore, the UK-based DNA sequencing technology spinout of University of Oxford, went public yesterday after issuing 82.4 million shares priced at £4.25 ($5.81) each for $478m in proceeds.

The initial public offering valued Oxford Nanopore at $4.7bn and existing shareholders, including commercialisation firm IP Group, offloaded $238m worth of stock.

Software producer Oracle had already committed to being a cornerstone investor for the IPO, putting aside $205m last week.

Shares soared 45% on the first day of trading…

Subscribe to go deeper

GCV subscribers get access to all our proprietary data and deep-dive articles, as well as the global directory of CVC investors.



Not sure if you have a subscription?
Thierry Heles

Thierry Heles is editor-at-large of Global University Venturing and Global Corporate Venturing, and host of the Beyond the Breakthrough podcast.
Email LinkedIn